Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PTM Biolabs

Explore full profile

High throughput proteomics technology and premium epigenetics reagents

Chicago, United StatesFounded 2011Biotech & Life Sciences
Valuation $250–500M Last recorded · 2020
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PTM Biolabs and the history behind them.

About PTM Biolabs

PTM Biolabs is a biotechnology startup that operates in the field of epigenetics and proteomics, which are areas of study that focus on understanding how genes function and proteins interact within the human body. The company offers a range of services, including drug research and development, in-depth blood proteomics, and pan PTM antibodies. These services are primarily targeted towards the healthcare and pharmaceutical industries, where they can be used to better understand complex human health and disease states.

The company's business model revolves around providing these specialized services to its clients. They generate revenue by charging for these services, which are likely to be in high demand given the increasing interest in personalized medicine and the growing need for more effective drugs and treatments.

PTM Biolabs also appears to be actively involved in industry events, such as the MEDICA and AACC Annual Meeting and Clinical Lab Expo. This suggests that the company is not only focused on its research but also on staying connected with the broader scientific community and keeping up-to-date with the latest developments in its field.

In terms of market, PTM Biolabs operates in the rapidly growing biotechnology industry. This industry is driven by advancements in technology and an increasing understanding of human biology, which are enabling new and innovative approaches to healthcare and medicine.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2011
Headquarters
Chicago, United States
Employees
29
Open positions
None listed
Dealroom signal
29.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Spinout, proteomics, DT and LS, science-based
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2020 $80M $320M IDG Capital · Highlight Capital · SDIC Venture Capital · Fortune Capital —
SPINOUTOther financing Jan 2011 $0 — The University of Chicago —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

PTM Biolabs website traffic

Latest recorded traffic for PTM Biolabs is 160 monthly website visits, down 79.5% over the last three months. PTM Biolabs's team declined 9.4% over the past year.

Latest monthly visits160 3-month web change-79.5% 1-year team growth-9.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • IDG Capital
  • Highlight Capital
  • SDIC Venture Capital
  • Fortune Capital

Other known investors1 additional known investor

  • The University of Chicago
Employees 29 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China89.5%
🇺🇸 United States10.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PTM Biolabs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PTM Biolabs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.